It may not be suitable if: You have one of the contraindicating conditions above
Cardiovasc Diabetol 21:172 Rodbard HW, Rosenstock J, Canani LH, Deerochanawong C, Gumprecht J, Lindberg SO, Lingvay I, Sondergaard AL, Treppendahl MB, Montanya E (2019) Oral semaglutide versus empagliflozin in patients with type 2 diabetes uncontrolled on metformin: the PIONEER 2 trial
Common side effects include nausea, mild stomach discomfort, and fatigue , which typically improve over time
This makes it particularly effective for treating uneven skin tone and stubborn dark patches
Copper peptides dont address this immune attack, so they are not a primary treatment
Some protocols recommend intramuscular injection into the worked muscle ("site injection"), with the theory that local IGF-1R stimulation drives localized hypertrophy